Jazz Pharmaceuticals (JAZZ)

Add to Watchlists
Create an Alert
141.58 -2.33  -1.62% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
JAZZ Price Chart
View All Events

JAZZ Events

Date Type Description
Feb 25 Misc Jazz Pharmaceuticals PLC Q4 2013 Earning Conference Call
Feb 25 Earnings Jazz Pharmaceuticals PLC Q4 2013 Earning Result. Estimate: 1.64.
Jan 13 Misc Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma of Rights to a Late Stage Investigational Compound for Excessive Daytime Sleepiness
Dec 19 Misc Jazz Pharmaceuticals Conference Call to Discuss Its Definitive Agreement to Acquire Gentium s.p.A
Dec 03 Misc Jazz Pharmaceuticals Announces Participation at the Piper Jaffray Healthcare Conference on December 3
Nov 05 Misc Jazz Pharmaceuticals Third Quarter 2013 Conference Call
Nov 05 Earnings Jazz Pharmaceuticals Third Quarter 2013 Release. Estimate: 1.50.
Aug 06 Earnings Jazz Pharmaceuticals to Report Second Quarter 2013 Financial Results on August 6, 2013. Estimate: 1.36.
Aug 06 Misc Q2 2013 Jazz Pharmaceuticals Earnings Conference Call
Aug 01 Misc AGM Event for Jazz Pharmaceuticals Plc
View All Performance Charts

JAZZ Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Jazz Pharmaceuticals is up 152.6% over the last year vs S&P 500 Total Return up 21.54%, Actelion up 67.22%, and Questcor Pharmaceuticals up 189.1%.

Get Quote for

PDF Report for JAZZ

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download JAZZ Pro Report PDF
Advertisement

Portfolio Strategies Featuring JAZZ

Did Jazz Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

JAZZ Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Ireland
  • Headquarters State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Jazz Pharmaceuticals Inc. is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind its mission to improve patients’ lives. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, severe chronic pain, psychiatry and women’s health. The company was founded in 2003.

Recent Quotes

Symbol Price Chg Chg % Market Cap
JAZZ 141.58 -2.33 -1.62% 8.188B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.